The expression of multiple components of the TME has a prognostic role, including tumor-infiltrating lymphocytes (TILs), CD8 + T cells, activated NK cells, and the CD8 +/Treg ratio (Dieci et al. 2021; Tavares et al. 2021). This evidence concerns the gene CD8A and neoplasm.